Skip to main content
Header image
User picture
Phone: +420 585 632 145
Groups: IMTM, LEM, POSTDOCTORAL FELLOW, STAFF

Postdoctoral training

Status: Ongoing.

About me

Researcher experienced in the field of cellular biology, microscopy, and flow cytometry with the main focus on studying the mechanism of action of newly synthesized cytotoxic compounds as potential anticancer drugs. GMO advisor at IMTM. Published >25 scientific papers and books/chapters, >312 SCI citations, H-index 10.

Journals

DAS, V., S. MODARRES MOUSAVI, N. ANNADURAI, S. SUKUR, F. MEHRNEJAD, M. MORADI, L. MALINA, M. KOLARIKOVA, V. RANC, I. FRYDRYCH, R. KOURIL, S. HOSSEINKHANI, M. HAJDÚCH, M. NIKKHAH
Hydrophobic residues in the α-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitors. Federation of European Biochemical Societies. 2025, ISSN: 1742-464X, PMID: 40819250,  PDF.
Triterpenoid derivatives inhibit Gli-mediated transcription in human glioblastoma cell line via direct interaction with Gli1. The Journal of biological chemistry. 2025, ISSN: 0021-9258, PMID: 40651614,  PDF.
Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells. ACS Omega. 2025, 10(10), 10617-10632, ISSN: 2470-1343, PMID: 40124057,  PDF.